News & Media
Former Press Releases (PDF)- October 2006: Cellzome Announces further Extension of Molecular Pathway Collaboration [+]
- July 2006: Galapagos and Cellzome in kinase drug discovery collaboration [+]
- July 2006: Cellzome announces Extension of Molecular Pathway Collaboration [+]
- July 2006: Cellzome appoints David Simmons as Chief Scientific Officer [+]
- January 2006: Cellzome and EMBL scientists publish the first genome-wide survey
of protein complexes [+] - October 2005: Cellzome and Graffinity awarded € 2.2 million grant from
German Ministry of Research and Education [+] - September 2005: Cellzome Concludes Collaboration with Bayer HealthCare [+]
- July 2005: Expansion of Pathway Collaboration with Novartis [+]
- May 2005: Ortho-McNeil Pharmaceutical exercises option to license Alzheimer's disease compounds [+]
- March 2005: Drug Discovery Collaboration in Alzheimer's Disease with Ortho-McNeil Pharmaceutical [+]
- September 2004: Partnership Agreement with Novartis [+]
- September 2004: Tim Edwards joins Cellzome as CEO [+]
- March 2004: Cellzome Moves UK Facilities to Cambridge, One of Europe’s Biggest
Biotech Hubs [+] - February 2004: A physical and functional map of the human TNF-α/NF-κB signal
transduction pathway. Nature Cell Biology Vol. 6 pp. 97-105 [+] - December 2003: Cellzome Signs Research Collaboration with Bayer HealthCare AG [+]
- October 2003: Research Collaboration with Johnson & Johnson Pharmaceutical R&D [+]
- March 2003: Cellzome Hits Target on Series C Financing [+]
- September 2002: Cellzome Appoints Dr. David Brown as President and CEO [+]
- January 2002: Cellzome Publishes Novel Approach For The Systematic Use Of
Protein Interaction Maps In Drug Discovery In Nature [+] - September 2001: Cellzome Acquires GlaxoSmithKline’s Cell Map Unit [+]
- March 2001: Cellzome Closes €34 million ($31 million) Private Placement in
Second Round of Financing [+]